Abstract #1757 Impact of Pre-Existing Liver Disease on Treatment and Outcomes of Breast Cancer – Robert Griffiths, et al.
The goal of this study was to explore the impact of pre-existing liver disease on the treatment and outcomes of breast cancer. Researchers identified 940 female subjects, average age 66 with mild to severe liver disease who were later diagnosed with breast cancer. Subjects were followed for up to a year during cancer treatment, and up to seven years for all forms of cancer and other mortality causes.
Conclusion: Basically, they found no differences in the treatment and breast cancer outcomes between patients with or without pre-existing liver disease. However, patients with pre-existing liver disease were more likely to die from other causes, specifically those diagnosed with stage II disease.
Editorial Comments: Multiple studies report an increased mortality rate in patients with liver disease, and specifically with viral hepatitis. Common sense tells us to treat a disease as early as possible, and hepatitis C is no exception.
Lucinda K. Porter, RN, is a long-time contributor to the HCV Advocate and author of “Free from Hepatitis C” and “Hepatitis C One Step at a Time.” She blogs at www.LucindaPorterRN.com and HepMag.com
Read the entire HCV Advocate newsletter